Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies

BACKGROUND/AIMS: Few reports have described the long-term treatment outcomes of the anti-tumor necrosis factor-α antibody for Japanese Crohn’s disease (CD) patients. The aim of this study was to evaluate them and clarify the clinical factors that affect the long-term prognosis of the anti-tumor necr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moroi, Rintaro, Endo, Katsuya, Yamamoto, Katsutoshi, Naito, Takeo, Onodera, Motoyuki, Kuroha, Masatake, Kanazawa, Yoshitake, Kimura, Tomoya, Kakuta, Yoichi, Masamune, Atsushi, Kinouchi, Yoshitaka, Shimosegawa, Tooru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361023/
https://www.ncbi.nlm.nih.gov/pubmed/30508475
http://dx.doi.org/10.5217/ir.2018.00048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361023/
https://www.ncbi.nlm.nih.gov/pubmed/30508475
http://dx.doi.org/10.5217/ir.2018.00048

Ejemplares similares